What is NDC 70771-1025?

70771-1025 is the product NDC for bumetanide, Bumetanide 1 mg/1 tablet, listed with the FDA by Zydus Lifesciences Limited. It has 5 package NDCs, shown above in 10- and 11-digit form.

Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for bumetanide?

122 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

bumetanide NDC 70771-1025 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1025Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1025Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70771-1025-0	7077110250070771102500	1000 TABLET in 1 BOTTLE (70771-1025-0)Marketed from May 1, 2018
70771-1025-1	7077110250170771102501	100 TABLET in 1 BOTTLE (70771-1025-1)Marketed from May 1, 2018
70771-1025-3	7077110250370771102503	30 TABLET in 1 BOTTLE (70771-1025-3)Marketed from May 1, 2018
70771-1025-5	7077110250570771102505	500 TABLET in 1 BOTTLE (70771-1025-5)Marketed from May 1, 2018
70771-1025-9	7077110250970771102509	90 TABLET in 1 BOTTLE (70771-1025-9)Marketed from May 1, 2018

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): bumetanide
Generic name (nonproprietary): bumetanide
Active ingredients: Bumetanide — 1 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Zydus Lifesciences LimitedNDC labeler code 70771
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202900
Marketing start: May 1, 2018
Listing expires: Dec 31, 2027
Other FDA classes: Increased Diuresis at Loop of Henle (Physiologic effect)
Identifiers: Product ID 70771-1025_58cd32ca-26d5-4d9f-9c08-38c80720d7b4SPL ID 58cd32ca-26d5-4d9f-9c08-38c80720d7b4SPL set ID 82eb62ca-c32b-4ff8-9f71-43219b240480RxCUI 197417, 197418, 197419UNII 0Y2S3XUQ5H
Pharmacologic class: Loop Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771102500 followed by a unit qualifier and the quantity

Package 70771-1025-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 5, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Bumetanide tablets USP are indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome. Almost equal diuretic response occurs after oral and parenteral administration of bumetanide. Therefore, if impaired gastrointestinal absorption is suspected or oral administration is not practical, bumetanide should be given by the intramuscular or intravenous route. Successful treatment with bumetanide tablets USP following instances of allergic reactions to furosemide suggests a lack of cross-sensitivity. CONTRAINDICATIONS Bumetanide is contraindicated in anuria. Although bumetanide tablets can be used …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70771-1025

What is NDC 70771-1025?: 70771-1025 is the product NDC for bumetanide, Bumetanide 1 mg/1 tablet, listed with the FDA by Zydus Lifesciences Limited. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: bumetanide.
What is the active ingredient?: Bumetanide.
Who is the labeler?: Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for bumetanide?: 122 other product NDCs are listed under this name. See all bumetanide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other bumetanide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Bumetanide	Bumetanide .5 mg/1	TabletOral	Sandoz Inc	0781-8099	00781-8099-0100781-8099-05
Bumetanide	Bumetanide 1 mg/1	TabletOral	Sandoz Inc	0781-8113	00781-8113-0100781-8113-05
Bumetanide	Bumetanide 2 mg/1	TabletOral	Sandoz Inc	0781-8160	00781-8160-01
Bumetanide	Bumetanide .25 mg/mL	Injection, SolutionIntramuscular, Intravenous	Civica, Inc.	72572-210	72572-0210-10
Bumetanide	Bumetanide .25 mg/mL	Injection, SolutionIntramuscular, Intravenous	Civica, Inc.	72572-211	72572-0211-10
Bumetanide	Bumetanide .25 mg/mL	InjectionIntramuscular, Intravenous	Cardinal Health 107, LLC	55154-5131	55154-5131-05
Bumetanide	Bumetanide 1 mg/1	TabletOral	NorthStar Rx LLC	72603-900	72603-0900-0172603-0900-02
Bumetanide	Bumetanide .5 mg/1	TabletOral	NorthStar Rx LLC	72603-889	72603-0889-01
Bumetanide	Bumetanide 2 mg/1	TabletOral	NorthStar Rx LLC	72603-901	72603-0901-0172603-0901-02
Bumetanide	Bumetanide .25 mg/mL	Injection, SolutionIntramuscular, Intravenous	Anthea Pharma Private Limited	83854-007	83854-0007-10

All 123 bumetanide NDCs

Other NDCs under ANDA 202900

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202900
Product	Strength	Form · route	Labeler	Product NDC
bumetanide	Bumetanide 1 mg/1	TabletOral	Bryant Ranch Prepack	71335-1692
bumetanide	Bumetanide .5 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1024
bumetanide	Bumetanide 2 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1026
bumetanide	Bumetanide .5 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	68382-525
bumetanide	Bumetanide 1 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	68382-526
bumetanide	Bumetanide 2 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	68382-527
bumetanide	Bumetanide 1 mg/1	TabletOral	A-S Medication Solutions	50090-6138
bumetanide	Bumetanide 2 mg/1	TabletOral	A-S Medication Solutions	50090-6137